Could zoledronic acid prevent root resorption in replanted rat molar?

Area of Science:

• Dental research
• Pharmacology
• Regenerative medicine

Background:

• External root resorption is a common complication following tooth avulsion and delayed replantation.
• Osteoclastic activity is a key factor in the progression of root resorption.
• Bisphosphonates, such as zoledronate, are known to inhibit osteoclast function.

Purpose of the Study:

• To evaluate the efficacy of zoledronate in suppressing external root resorption after delayed replantation in a rat model.
• To determine the optimal dosage of zoledronate for inhibiting root resorption.
• To assess the impact of zoledronate on osteoclastic activity and subsequent root repair.

Main Methods:

• Maxillary first molars were extracted, dried, and replanted in Sprague Dawley rats (N=84).
• Rats were divided into groups receiving 1 mM alendronate or 1, 5, 10, 20, or 40 μM zoledronate.
• Radiographic and histological analyses were performed at 4 and 8 weeks postreplantation.

Main Results:

• At 8 weeks, zoledronate (10, 20, 40 μM) significantly reduced periapical lesions and increased radiopacity compared to controls.
• Histological analysis showed a reduced rate of inflammatory root resorption at 8 weeks with 20 and 40 μM zoledronate (P < 0.05).
• No significant differences in replacement resorption were observed across groups.

Conclusions:

• Zoledronate effectively inhibits external root resorption in a delayed replantation model.
• A 20 μM dosage of zoledronate demonstrated the most significant long-term efficacy in preventing root resorption.
• Zoledronate shows promise as a therapeutic agent for managing root resorption after delayed tooth replantation.